2-3 Financial Statement Review

Search Synopsis Change Company

Johnson & Johnson (NYS: JNJ) + to Company Analysis List Address: One Johnson & Johnson Plaza,New Brunswick, NJ 08933 United States | Phone: 732 524-0400 | Fax: 732 214-0332 | Company Website: www.jnj.com

Incorporated: November 1887 , NJ, United States IRS Number: 221024240 CUSIP: 47816010 Auditor: PricewaterhouseCoopers LLP Transfer Agent: Computershare Trust Company, N.A., Canton, MA Country: United States

Sector: Pharmaceuticals Industry: Pharmaceutical preparations (SIC 2834) Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412) Number of Employees: 135,100 (Approximate Full-Time as of 12/30/2018) Number of Shareholders: 142,029 (record) (as of 02/15/2019)

Market Cap: 362,540,368,000 Revenue: 81,706,000,000 Net Income: 14,151,000,000 Dividend: 3.75 Dividend Yield: 2.7223 EPS Basic: 5.32 EPS Diluted: 5.25 PE Ratio: 26.2381

Company details Executives Ownership Company financials Equity pricing Reports Filings News Competitors Report builder

Download Printer Friendly My Mergent Tools

Competitor (Public USA Public Global Private)

Click here to create a competitor report

Add Company to Competitor List : Add all to Company Analysis List

Competitor News McKesson Corp Federal opioid probe targets drug firms timeunion.com - 1:17AM, 28 November 2019

Schwab's headquarters shift to Texas amid TD Ameritrade merger seems to please nobody -- outside the Dallas Chamber of Commerce--Omaha feels especially omitted RIABiz - 12:07AM, 28 November 2019

Johnson & Johnson Hedge Funds Are Standing By Johnson & Johnson (JNJ) Insider Monkey - 10:07AM, 28 November 2019

Pharma Tech Solutions, Inc. v. Lifescan, Inc. (Fed. Cir. 2019) Patent Docs - 12:01AM, 28 November 2019

Procter & Gamble Company (The) Permanent Link to First Heartland Consultants Inc. Sells 428 Shares of Procter & Gamble Co (NYSE:PG) The Olympia Report - 1:19PM, 28 November 2019

Procter & Gamble India sets up ₹200 crore environmental sustainability fund livemint - 8:06AM, 28 November 2019

Pfizer Inc 10 Million Shequel Claim for at Risk Launch of Generic Viagra Thrown Out The IP Factor - 3:05PM, 28 November 2019 Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Pfizer Inc - 12:10PM, 27 November 2019

Merck & Co Inc Nomination Process Is Open For Verdantix 2020 Operational Excellence Innovation Awards Business Wire - 4:05AM, 29 November 2019 Parametric Portfolio Associates LLC Grows Position in Merck & Co., Inc. (NYSE:MRK) Tech Know Bits - 6:51PM, 28 November 2019

AbbVie Inc Announcement Under The Irish Takeover Rules: Relevant Securities In Issue - November 29, 2019 The Street - 2:19PM, 29 November 2019 AbbVie and NorthWest EHealth announce partnership to explore autoimmune conditions Pharmaceutical Field - 9:42AM, 28 November 2019

Abbott Laboratories Bank of Hawaii Has $4.70 Million Holdings in Abbott Laboratories (NYSE:ABT) Tech Know Bits - 8:02AM, 29 November 2019 Abbott Laboratories (NYSE:ABT) Shares Sold by Voya Financial Advisors Inc. Tech Know Bits - 9:39PM, 28 November 2019

Lilly (Eli) & Co

Log Out | Administration | Contact Us | Help | Training Calendar Version 2.04

11/29/2019, 8:51:04 PM

Pow ered by Clearbit

Remove Company Name Revenues Gross Margin

Net Income EBITDA Total Assets Total Liabilities PE Ratio Market Cap Employees Share Price

X McKesson Corp 214,319,000,000 5.48 34,000,000 1,109,000,000 59,672,000,000 51,578,000,000 - 26,360 M 60,000 146.29

X Johnson & Johnson 81,581,000,000 66.79 15,297,000,000 25,393,000,000 152,954,000,000 93,202,000,000 26.2381 362,540 M 135,100 137.75

X Procter & Gamble Company (The) 67,684,000,000 48.63 3,897,000,000 9,182,000,000 115,095,000,000 67,901,000,000 77.5541 303,647 M 97,000 121.76

X Pfizer Inc 53,647,000,000 79.03 11,153,000,000 17,761,000,000 159,422,000,000 96,015,000,000 13.4132 213,783 M 92,400 38.63

X Merck & Co Inc 42,294,000,000 68.06 6,220,000,000 10,530,000,000 82,637,000,000 55,936,000,000 24.4721 223,054 M 69,000 87.61

X AbbVie Inc 32,753,000,000 76.44 5,687,000,000 8,106,000,000 59,352,000,000 67,798,000,000 38.9119 130,624 M 30,000 88.33

X Abbott Laboratories 30,578,000,000 58.45 2,368,000,000 6,872,000,000 67,173,000,000 36,649,000,000 46.4239 151,062 M 103,000 85.42

X Lilly (Eli) & Co 24,555,700,000 73.81 3,232,000,000 4,786,100,000 43,908,400,000 34,079,700,000 14.2871 112,758 M 38,680 117.44

X Amgen Inc 23,747,000,000 82.73 8,394,000,000 10,893,000,000 66,416,000,000 53,916,000,000 18 139,360 M 21,500 234.54

X Bristol-Myers Squibb Co. 22,561,000,000 70.98 4,920,000,000 6,656,000,000 34,986,000,000 20,955,000,000 - 93,847 M 23,300 57.60

X Gilead Sciences Inc 22,127,000,000 78.07 5,455,000,000 9,102,000,000 63,675,000,000 42,288,000,000 31.8104 84,917 M 11,000 67.12

X Regeneron Pharmaceuticals, Inc. 6,710,800,000 93.53 2,444,400,000 2,725,800,000 11,734,500,000 2,977,200,000 19.8919 40,111 M 7,400 371.58

X Zoetis Inc 5,825,000,000 67.19 1,428,000,000 2,134,000,000 10,777,000,000 8,592,000,000 40.1419 57,932 M 10,000 121.63

X Syneos Health Inc 4,390,116,000 21.77 24,284,000 256,431,000 7,254,909,000 4,398,765,000 67.2744 5,726 M 24,000 55.17

X Alexion Pharmaceuticals Inc. 4,131,200,000 90.94 77,600,000 738,400,000 13,931,900,000 4,766,600,000 17.5574 25,371 M 2,656 114.65

X Edwards Lifesciences Corp 3,722,800,000 74.77 722,200,000 834,200,000 5,323,700,000 2,183,300,000 67.2842 51,362 M 12,800 246.26

X Elanco Animal Health Inc 3,066,800,000 42.25 86,500,000 422,400,000 8,956,700,000 3,759,200,000 89.9032 10,396 M 5,590 27.87

X Vertex Pharmaceuticals, Inc. 3,047,597,000 86.56 2,096,896,000 706,760,000 6,245,898,000 1,810,695,000 26.6417 56,588 M 2,500 220.06

X Catalent Inc 2,518,000,000 31.97 137,400,000 411,600,000 6,184,000,000 3,895,800,000 56.617 7,787 M 12,300 53.22

X Idexx Laboratories, Inc. 2,213,242,000 56.10 377,031,000 565,543,000 1,537,349,000 1,546,862,000 52.1206 21,506 M 8,377 250.70

X Incyte Corporation 1,881,883,000 95.00 109,493,000 149,190,000 2,645,762,000 719,795,000 50.6022 20,273 M 1,367 94.12

X Amneal Pharmaceuticals Inc 1,662,991,000 43.08 (169,726,000) 5,266,000 4,352,736,000 3,847,986,000 - 440 M 6,000 3.28

X United Therapeutics Corp 1,627,800,000 87.79 589,200,000 780,000,000 3,401,000,000 593,200,000 - 4,119 M 860 93.87

X Nektar Therapeutics 1,193,323,000 97.95 681,313,000 734,303,000 2,150,172,000 432,597,000 - 3,613 M 618 20.54

X Fresenius Kabi Pharmaceuticals Holdings Inc

1,142,671,000 50.46 109,569,000 491,225,000 4,703,166,000 4,057,510,000 - 20 1,472 0.02

Mergent Online - Competitors : Johnson & Johnson https://www-mergentonline-com.proxy-library.ashford.edu/competitors....

1 of 2 11/29/2019, 8:51 PM

Permanent Link to Wealthsource Partners LLC Increases Stake in Eli Lilly And Co (NYSE:LLY) The Olympia Report - 2:14PM, 29 November 2019

Permanent Link to Point72 Asset Management L.P. Buys New Shares in Eli Lilly And Co (NYSE:LLY) The Olympia Report - 4:16PM, 28 November 2019

Amgen Inc Novartis Deal for Heart Drug Hinges on Succeeding Where Rivals Struggle Morningstar - 6:45AM, 29 November 2019

Hedge Funds Getting Excited About Parsley Energy Inc (PE) Daily Magazine - 11:26PM, 28 November 2019

Bristol-Myers Squibb Co. Stifel Financial Corp Boosts Stock Holdings in Bristol-Myers Squibb Co (NYSE:BMY) - Modern Readers MR Modern Readers - 3:19PM, 28 November 2019

Vicus Capital Takes $319,000 Position in Bristol-Myers Squibb Co (NYSE:BMY) - Modern Readers MR Modern Readers - 2:16PM, 28 November 2019

Gilead Sciences Inc Permanent Link to Metropolitan Life Insurance Co NY Sells 38,029 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) The Olympia Report - 2:14PM, 29 November 2019

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Bank of Hawaii Tech Know Bits - 11:44AM, 29 November 2019

Regeneron Pharmaceuticals, Inc. Permanent Link to Orbimed Advisors LLC Increases Stock Position in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) The Olympia Report - 6:14PM, 29 November 2019

Novartis' Latest Acquisition Of The Medicines Company Sets It Up For A Large Market Seeking Alpha - 9:20PM, 26 November 2019

Zoetis Inc Zoetis Inc (NYSE:ZTS) Shares Sold by Worldquant Millennium Advisors LLC Tech Know Bits - 11:50AM, 29 November 2019

Zoetis Inc (NYSE:ZTS) Shares Sold by SRS Capital Advisors Inc. Tech Know Bits - 9:55AM, 29 November 2019

Syneos Health Inc INC Research Further Strengthens Board of Directors Through Appointment of Pharmaceutical Executive David Norton GlobeNewswire - 2:40PM, 4 February 2015

INC Research: A Biopharma Derivative With A Bright Future Seeking Alpha - 6:59PM, 28 January 2015

Alexion Pharmaceuticals Inc. It's Been a Particularly Exciting Year for Biotech Stocks Across the Board PR Newswire - 9:07AM, 27 November 2019

SOLIRIS® (eculizumab) Receives Approval In Japan For The Prevention Of Relapse In Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) The Street - 9:23AM, 22 November 2019

Edwards Lifesciences Corp Permanent Link to National Pension Service Purchases 12,368 Shares of Edwards Lifesciences Corp (NYSE:EW) The Olympia Report - 3:14PM, 29 November 2019

RKL Wealth Management LLC Sells 467 Shares of Edwards Lifesciences Corp (NYSE:EW) Tech Know Bits - 1:01PM, 19 November 2019

Elanco Animal Health Inc ELANCO ANIMAL HEALTH INC (ELAN) Q3 2019 Earnings Call Transcript NetDania - 3:23PM, 6 November 2019

Elanco Animal Health Reports Third Quarter Results Global Banking & Finance Review - 8:32AM, 6 November 2019

Vertex Pharmaceuticals, Inc. Biotech Tops in November: Best ETFs & Stocks Daily Magazine - 2:49PM, 29 November 2019

Hedge Funds Are Warming Up To Vertex Pharmaceuticals Incorporated (VRTX) Wall Street Reporter, Inc. - 10:21PM, 28 November 2019

Catalent Inc Catalent Inc. Announces First Quarter Fiscal Year 2015 Earnings Conference Webcast PharmiWeb - 5:00PM, 16 October 2014

Idexx Laboratories, Inc. $599.94 Million in Sales Expected for IDEXX Laboratories, Inc. (NASDAQ:IDXX) This Quarter - Modern Readers MR Modern Readers - 9:25PM, 23 November 2019

IDEXX Laboratories (NASDAQ:IDXX) Releases Earnings Results, Beats Expectations By $0.10 EPS Tech Know Bits - 6:19AM, 23 November 2019

Incyte Corporation Sumitomo Mitsui Trust Holdings Inc. Has $69.07 Million Stake in Incyte Co. (NASDAQ:INCY) Tech Know Bits - 5:56AM, 29 November 2019

Incyte Announces Acceptance and Priority Review of NDA for Pemigatinib as a Treatment for Patients with Cholangiocarcinoma DMN Newswire - 8:08AM, 27 November 2019

Amneal Pharmaceuticals Inc Parkinsons Disease Drugs Market Revenue, Trends, Demand and Forecast to 2022 Market Watch - 2:19AM, 20 November 2019

LifeMax Receives Orphan Drug Designation From the European Commission for LM-030 for the Treatment of Netherton Syndrome Business Wire, Inc. - 7:55AM, 13 November 2019

United Therapeutics Corp Wedbush Securities Inc. Has $320,000 Stock Position in United Therapeutics Co. (NASDAQ:UTHR) Tech Know Bits - 1:02AM, 15 November 2019

United Therapeutics (NASDAQ:UTHR) Rating Increased to Buy at BidaskClub Tech Know Bits - 9:49PM, 4 November 2019

Nektar Therapeutics Nektar Therapeutics (NASDAQ:NKTR) Releases Quarterly Earnings Results Tech Know Bits - 10:55AM, 29 November 2019

Nektar Therapeutics (NASDAQ:NKTR) Releases Earnings Results Tech Know Bits - 11:01PM, 13 November 2019

Fresenius Kabi Pharmaceuticals Holdings Inc Patrick Soon-Shiong – Owner and Executive Chairman Los Angeles Times - 1:59PM, 22 June 2018 FEMALE HEALTH CO - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations Equities.com - 5:38PM, 12 December 2016

Mergent Online - Competitors : Johnson & Johnson https://www-mergentonline-com.proxy-library.ashford.edu/competitors....

2 of 2 11/29/2019, 8:51 PM